Stocktoria

Vicapsys Life Sciences, Inc. VICP

OTC · stock · Pharmaceutical Preparations · website · IPO 2001-07-11

Vicapsys Life Sciences, Inc. statistics & valuation

Market cap$47.3M

Market cap as of 2026-07-01. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
20192020202120222023
Operating margin (%)
20192020202120222023
Return on equity (%)
-466.90% 20192020202120222023
Shares outstanding
17.5M 17.5M 19.7M 31.2M 34.5M 20192020202120222023
Net debt ($)
20192020202120222023
Share buybacks ($)
20192020202120222023
Return on assets (%)
-201.80% -189.50% -39.90% -1367.40% -2980.90% 20192020202120222023
Free cash flow margin (%)
20192020202120222023
Debt / equity (×)
20192020202120222023
EPS ($)
-$0.03 -$0.03 20192020202120222023

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2023FY2022FY2021FY2020FY2019
Return on assets-2980.9%-1367.4%-39.9%-189.5%-201.8%
Return on equity61.3%103.6%194.7%170.5%-466.9%
Current ratio0.020.070.310.000.67

Computed from company filings · US · as of 2023-12-31. Facts plus Stocktoria's own computed scores — not investment advice.